The Studys Key Findings Hannah : Your recent study, published in the Journal of Pharmacy and Pharmacology Research, examined how probiotics impact GLP-1 agonist treatment
They reduce visceral fat, the dangerous inflammation-driving fat stored around your organs
[3] The same work profiled shifts in the cecal microbiome associated with treatment
Furthermore, the administration of TNBS in 50% ethanol resulted in an additive injury with respect to either TNBS+saline or 50% ethanol, an effect that was accompanied by a significant depletion of mucosal GSH content
Reduced or conjugated curcumin forms, such as 4HC, 6HC, and curcumin sulfate, showed a diminished ability to inhibit cyclooxygenase-2 (COX-2) synthesis (108)
Switching is possible but must be managed carefully by a healthcare professional